Skip to content

Elaine Schattner

writer, health care advocate, physician

  • about
  • academic
  • journalist
  • portfolio
  • patient advocate
  • speaker
  • contact

For Treatment Of Polycythemia Vera, FDA Approves Jakafi, A Targeted Therapy

hematology, leukemia, meds, oncology, oral, precision medicine, targeted therapy, treatment
as seen in Forbes

The kinase inhibitor offers a new option for people with polycythemia vera, a condition for which few drugs have been available.

Related

FDA approvalJakafikinase inhibitorp. verapolycythemia vera

More Projects

  • Why News About Thyroid Cancer Screening Doesn’t Apply To Breast Cancer

    Why News About Thyroid Cancer Screening Doesn’t Apply To Breast Cancer

  • For Treatment Of Polycythemia Vera, FDA Approves Jakafi, A Targeted Therapy

    For Treatment Of Polycythemia Vera, FDA Approves Jakafi, A Targeted Therapy

  • ‘Lily,’ A Film About A Young Artist With Breast Cancer, And What’s Next In Her Life

    ‘Lily,’ A Film About A Young Artist With Breast Cancer, And What’s Next In Her Life

  • about
  • academic
  • journalist
  • portfolio
  • patient advocate
  • speaker
  • contact
Proudly powered by WordPress | Theme: Sketch by WordPress.com.